Use this button to switch between dark and light mode.

I Can See Clear(er) Now: Prescription Drug Reporting

May 17, 2022 (2 min read)

A new prescription drug reporting mandate, which was adopted as part of the 2021 Consolidated Appropriations Act (CAA) (Pub. L. No. 116-260), requires group health plans and health insurers to report detailed data about prescription drug pricing (including rebates) and healthcare spending. The first reports are due by December 27, 2022, and annually thereafter. 

READ NOW »


Related Content

  • Transparency in Coverage, No Surprises Act, and Consolidated Appropriations Act, 2021 Requirements Checklist
    Learn more by reading this checklist, in chart format, which lists new requirements for health plans, health insurance issuers, and providers regarding transparency, balance billing, and other matters imposed under (1) the Transparency in Coverage rules (extending rules of the Patient Protection and Affordable Care Act (ACA)); (2) the No Surprises Act (enacted as Title I of Division BB of the CAA); and (3) additional rules enacted under CAA, Division BB, Title II.

Practical Guidance Updates
Featuring the latest updates from your Practical Guidance account.   


Experience results today with practical guidance, legal research, and data-driven insights—all in one place.

Experience Lexis+